锌α2糖蛋白指数—评价胰岛素敏感性的简易指标
[Abstract]:The first part explores the relationship between zinc alpha 2 glycoprotein and insulin sensitivity in obese subjects with different glucose tolerance Objective: To explore the relationship between zinc glycoprotein (ZAG) and insulin sensitivity (IS) in obese subjects with different glucose tolerance. Sixty-seven obese patients with impaired glucose tolerance and 83 obese patients with type 2 diabetes mellitus were enrolled in the study. Oral glucose tolerance test (OGTT), oral glucose insulin release test (OGIRT) and anthropometric and clinical parameters were measured. Free ZAG levels were measured by enzyme-linked immunosorbent assay (ELISA). T test was used to compare ZAG, anthropometric indicators and clinical indicators in different disease groups; secondly, linear correlation analysis and partial correlation analysis were used to explore the correlation between ZAG and homeostasis model insulin resistance index (HOMA-IR), anthropometric indicators and clinical indicators; secondly, multiple linear regression was used to explore the relationship between ZAG and insulin. Results: The waist circumference (WC), hip circumference (HC), waist-hip ratio (WHR), systolic blood pressure (SBP), diastolic blood pressure (DBP), fasting plasma glucose (FPG), plasma glucose (2h-PG), HbA1c, total cholesterol (TC), triglyceride (TG), HOMA-IR, fasting serum insulin (FIns) and 2 h-postprandial serum insulin (2h-PG) in obese patients with type 2 diabetes mellitus were measured. Ins was higher than obesity with normal glucose tolerance (P 0.05 or P 0.01), whereas HDL-C and free ZAG levels were lower than obesity with normal glucose tolerance (P 0.01). After adjusting for sex and age, ZAG was negatively correlated with HOMA-IR. R = 0.583, P 0.01). Conclusion: ZAG is positively correlated with insulin sensitivity in obese patients with different degrees of glucose tolerance. Zinc glycoprotein index (ZAG index), i.e. Ln [Zinc alpha2 glycoprotein/homeostasis model insulin resistance index] (Ln [ZAG/HOMA-IR]), was compared with some existing indicators for assessing insulin sensitivity. ZAG index was used as a simple index for assessing insulin sensitivity (IS) in patients with polycystic ovary syndrome (PCOS). A total of 202 subjects including 102 PCOS patients and 100 normal controls were enrolled in the study. EHC was performed to assess insulin sensitivity. OGTT, OGIRT, anthropometric and clinical indices were detected. Levels of free ZAG and adiponectin (ADI) were measured by ELISA. Firstly, anthropometric and clinical indices were compared in PCO with t test. Statistical differences between S group and control group were compared, and ZAG index, HOMA-IR, ADI/HOMA-IR and other indicators in insulin resistance group and non-resistant group were compared. Secondly, the correlation between ZAG index and anthropometric indicators and clinical indicators was explored by partial correlation analysis, and ZAG index, HOMA-IR, ADI/HOMA-IR and other indicators were explored by partial correlation analysis. The relationship between ZAG index and M value was further explored by multivariate linear regression. Logistic regression was used to explore whether insulin sensitivity, ZAG index, ADI/HOMA-IR and other indices were protective factors or risk factors. The consistency between ZAG index and M value was analyzed. Finally, the effectiveness of ZAG index in diagnosing insulin sensitivity was evaluated by AUC and Youden index of ROC curve. The best cut-off point of ZAG index in diagnosing insulin sensitivity and the corresponding sensitivity and specificity were analyzed. On the contrary, TG / HDL - C, TyG, I / G, HOMA - IR in insulin resistance group were higher than those in non - insulin resistance group. Partial correlation suggested that the correlation coefficient between ZAG index and M value was (r = 0.779, P 0.01), not lower than that between HOMA - IR and ADI / HOMA - IR and M value (r = - 0.623, P 0.01) and (r = 0.604, P 0.01). The correlation coefficients of TyG (r = - 0.394, P 0.01), I / G (r = - 0.598, P 0.01) and TG / HDL - C (r = - 0.237, P < 0.01) with M value were not lower than those of TyG (r = - 0.394, P 0.01). Multivariate linear regression analysis suggested that YZAG index = 4.277 + 0.1 XM value - 0.079XFIns - 0.248 XFPG (R2 = 0.896, P 0.001) was a protective factor for insulin sensitivity, and logistic regression suggested that ZMAG index and ADI / HO were protective factors for insulin sensitivity. TyG.TG/HDL-C, HOMA-IR, and I/G were risk factors. Furthermore, in the consistency test between ZAG index and M value, the consistency coefficient of weighted K test was 0.502, and the Pearson contingency number r = 0.741. Finally, in the ROC curve analysis, the area under the curve (AUC) of ZAG index for insulin sensitivity diagnosis was close to 1 and not lower than the other indexes. The best cut-off point of ZAG index was 2.97, and the sensitivity and specificity were 87.8% and 90.8% respectively. Youden index was 0.786. Conclusion: ZAG index can be used as a simple index to evaluate the insulin sensitivity of PCOS patients.
【学位授予单位】:重庆医科大学
【学位级别】:硕士
【学位授予年份】:2015
【分类号】:R589.2;R587.1
【相似文献】
相关期刊论文 前10条
1 游捷,陈瑶,黄培基,林哲章;血清可溶性肿瘤坏死因子受体与胰岛素抵抗的关系[J];中华内分泌代谢杂志;2002年01期
2 杨凌辉,邹大进;肥胖致胰岛素抵抗的机制[J];中华内分泌代谢杂志;2002年03期
3 管立学,王敬先,王景明,陈亮,朱国明,王瑞丽;血管紧张素转换酶基因多态性与胰岛素抵抗的临床应用研究[J];中华检验医学杂志;2002年02期
4 刘铁迎;微血管内皮异常与胰岛素抵抗[J];中国老年学杂志;2002年01期
5 蔡红卫;脂联素与胰岛素抵抗的研究进展[J];重庆医学;2002年11期
6 时海波,程雷,徐其昌;阻塞性睡眠呼吸暂停综合征与胰岛素抵抗[J];临床耳鼻咽喉科杂志;2003年05期
7 卢德成,罗佐杰;肥胖与胰岛素抵抗有关调控因素的研究进展[J];临床荟萃;2003年16期
8 周昭明;小剂量胰岛素治疗糖尿病酮症酸中毒68例观察[J];国际医药卫生导报;2003年12期
9 王继旺;吸烟与胰岛素抵抗[J];国外医学(内分泌学分册);2003年04期
10 杨瑞平 ,甘晓健;老年2型糖尿病患者血清瘦素与胰岛素及胰岛素抵抗关系的探讨[J];广西医学;2003年11期
相关会议论文 前10条
1 李晨钟;张素华;舒昌达;任伟;;氯喹对胰岛素抵抗大鼠胰岛素降解酶基因及酶蛋白表达的影响[A];中华医学会第六次全国内分泌学术会议论文汇编[C];2001年
2 刘铁迎;高鑫;江孙苏;孙璇;周庭川;姚君厘;余丹青;雪怡;;肥胖患者胰岛素抵抗和血浆vWF水平的变化[A];中华医学会第六次全国内分泌学术会议论文汇编[C];2001年
3 都健;刘国良;;胰岛素抵抗大鼠内皮依赖性血管舒张功能及其发生机制的研究[A];中华医学会第六次全国内分泌学术会议论文汇编[C];2001年
4 曲波;;中医药防治胰岛素抵抗的研究进展[A];第七次中国中西医结合糖尿病学术会议论文汇编[C];2004年
5 李光伟;;胰岛素抵抗评估[A];第八次全国妇产科学学术会议论文汇编[C];2004年
6 郭正宇;尹卫东;宋砚明;邓小健;;褪黑素改善胰岛素抵抗大鼠海马胰岛素信号通路障碍[A];湖南省生理科学会2008年度学术年会论文摘要汇编[C];2008年
7 张荣;单慧敏;赵三妹;许荣q;;高脂饲料诱导的大鼠胰岛素抵抗及与血清瘦素的关系[A];加入WTO和中国科技与可持续发展——挑战与机遇、责任和对策(下册)[C];2002年
8 柴国禄;谭丽艳;杨玉红;刘晶砾;李丽疆;;糖尿病合并高血压患者胰岛素抵抗与血浆血管紧张素Ⅱ及内皮素的关系[A];中华医学会第六次全国内分泌学术会议论文汇编[C];2001年
9 陈莹;高彦彬;;中医药对胰岛素抵抗及胰岛素抵抗综合征的研究进展[A];第七次全国中医糖尿病学术大会论文汇编[C];2003年
10 孙琳;班博;于世鹏;孙冰;赵秀贞;;胰岛素抵抗、血脂与老年2型糖尿病合并高血压的关系[A];第三届全国老年医学进展学术会议论文集[C];2003年
相关重要报纸文章 前10条
1 孟怀东;“致命四重奏”与胰岛素抵抗[N];中国医药报;2007年
2 ;应正确认识胰岛素[N];医药养生保健报;2006年
3 ;哪些人不宜过早应用胰岛素[N];医药导报;2008年
4 刘燕玲;中医药防治胰岛素抵抗[N];健康报;2002年
5 本报记者赵晴晴;胰岛素治疗后为何发胖?[N];健康时报;2003年
6 本报特约记者 徐夕;“口服植物胰岛素”并不存在[N];卫生与生活报;2005年
7 河南省郑州市第三人民医院内分泌科副主任医师 刘龙诞邋陈锦屏 整理;胰岛素抵抗试试增敏剂[N];健康报;2007年
8 董飞侠;解开胰岛素抵抗密码[N];医药经济报;2006年
9 北京协和医院主任医生 姚我清;胰岛素抵抗的药物治疗[N];医药养生保健报;2006年
10 指导专家 全军糖尿病诊治中心、306医院内分泌科副主任 刘彦君 博士;现在开始,,让您的胰岛素活起来![N];医药导报;2007年
相关硕士学位论文 前10条
1 于婷;胰岛素抵抗大鼠硫化氢/胱硫醚γ—裂解酶体系的实验观察[D];山东大学;2007年
2 甘宇;2型糖尿病患者血清真胰岛素水平与血脂的关系研究[D];中国医科大学;2003年
3 杨卫红;高糖和胰岛素对鼠骨髓间充质干细胞增殖的影响及其机制研究[D];华中科技大学;2007年
4 李小宁;骨骼肌组织磷脂酰肌醇3激酶表达与妊娠期糖尿病胰岛素抵抗关系研究[D];青岛大学;2008年
5 侯连国;胰岛素抵抗与2型糖尿病大鼠心肌脂肪酸代谢相关基因转录水平的改变[D];河北医科大学;2009年
6 邓娟;围术期胰岛素抵抗相关影响因素的分析[D];中南大学;2009年
7 李海东;蛋白质酪氨酸硝化对胰岛素磷酸化信号的影响[D];华中科技大学;2008年
8 张红玉;哈萨克族肥胖、胰岛素抵抗与糖调节异常的关系[D];新疆医科大学;2009年
9 刘慧琳;胰岛素抵抗与绝经后骨质疏松症的关系初探[D];四川大学;2005年
10 张俊防;真胰岛素、胰岛素原与2型糖尿病大血管病[D];河北医科大学;2002年
本文编号:2229526
本文链接:https://www.wllwen.com/yixuelunwen/nfm/2229526.html